The PE Ratio as of November 2024 (TTM) for Exscientia plc (EXAI) is -3.21

According to Exscientia plc’s latest financial reports and current stock price. The company's current PE Ratio is -3.21. This represents a change of -7.46% compared to the average of -3.47 of the last 4 quarters.

Exscientia plc (EXAI) Historical PE Ratio (quarterly & annually)

How has EXAI PE Ratio performed in the past?

The mean historical PE Ratio of Exscientia plc over the last ten years is -86.57. The current -3.21 PE Ratio has changed 270.78% with respect to the historical average. Over the past ten years (40 quarters), EXAI's PE Ratio was at its highest in in the September 2024 quarter at 0. The PE Ratio was at its lowest in in the September 2019 quarter at -286506.05.

Exscientia plc (EXAI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Exscientia plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Exscientia plc (EXAI) Average PE Ratio

How has EXAI PE Ratio performed in the past?

The current PE Ratio of Exscientia plc (EXAI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Exscientia plc (EXAI) PE Ratio vs. Peers

How is EXAI’s PE Ratio compared to its peers?

Exscientia plc’s PE Ratio is greater than VectivBio Holding AG (-7.94), greater than Zura Bio Limited (-5.60), less than Elevation Oncology, Inc. (-0.85), greater than Icosavax, Inc. (-15.78), greater than Recursion Pharmaceuticals, Inc. (-4.27), less than Atea Pharmaceuticals, Inc. (-1.64), less than Unity Biotechnology, Inc. (-0.88), greater than Adaptimmune Therapeutics plc (-3.77), greater than Mereo BioPharma Group plc (-13.56), less than Pieris Pharmaceuticals, Inc. (-1.39), less than PDS Biotechnology Corporation (-1.90), less than Leap Therapeutics, Inc. (-1.63), greater than Theseus Pharmaceuticals, Inc. (-6.29), less than aTyr Pharma, Inc. (-2.33), less than Relay Therapeutics, Inc. (-1.93), less than Century Therapeutics, Inc. (-0.79), greater than Blueprint Medicines Corporation (-46.60), greater than Revolution Medicines, Inc. (-16.70), less than Sana Biotechnology, Inc. (-2.01), greater than Kymera Therapeutics, Inc. (-20.45), greater than Monte Rosa Therapeutics, Inc. (-5.83),

Build a custom stock screener for Exscientia plc (EXAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exscientia plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exscientia plc (EXAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exscientia plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.